India to resume COVID-19 vaccine exports

India says it will resume exporting coronavirus vaccines later this year, after suspending shipments in April as infections skyrocketed in the country.

India, one of the world's largest vaccine suppliers, granted or exported domestically-produced Astrazeneca vaccines to other countries before the halt.

The country saw more than 400,000 new cases per day in early May. But the recent daily figure has dropped to about 30,000.

Health minister Mansukh Mandaviya announced on Monday the planned resumption of vaccine exports in the October to December quarter.
He said the country's monthly vaccine output is set to reach 300 million doses next month.

India's suspension has dealt a serious blow to the global vaccine rollout, as the country was supposed to provide 70 percent of the supply for COVAX program in the first half of the year. The UN-backed scheme aims to provide inoculations to the neediest people in the world.

The Indian government has yet to elaborate on details, including exactly when it will restart exports and how much it will supply. But the government says it will fulfil its responsibility toward COVAX.